Joint FDA Advisory Committee Votes Not to Recommend Pain Therapeutics’ Oxycodone NDA

Remoxy ER, Pain Therapeutics’ new oxycodone pain relief candidate, failed to sway FDA advisory committee members this week.
Source: Drug Industry Daily